SA and Zambia’s HIV shot dilemma: Demand versus supply
South Africa and Zambia are grappling with a significant challenge in rolling out lenacapavir, a new six-monthly HIV prevention injection. Despite high demand and promising early results, limited supplies mean clinics often run out of stock, creating a complex balancing act between generating awareness and ensuring equitable access.
We haven't written up this one. Mail and Guardian has the full story — the link below goes straight to it.